Hawthorne Health and RxE2 Partner to Expand Patient Access in Clinical Trials
WALNUT CREEK, CA. & FARGO, ND, January 30, 2025 Hawthorne Health, the leader in community trial delivery, and RxE2, a pioneer in pharmacist-led clinical trial
Success
Thank you for reaching out to us
We appreciate hearing from you, and a member of our team will reply as soon as possible. In the meantime, we invite you to review some of our publications and other resources below to learn more about how Hawthorn Effect is changing clinical trials.
Articles
cardiovascular
Case Study: Hawthorne Health’s Support for BTK Clinical Trials
Hawthorne Health (HH) partnered with sponsors conducting clinical trials for cardiovascular disease (CVD), specifically targeting BTK (below-the-knee) conditions, like Chronic Limb Ischemia. … Read More
Hawthorne Health Strengthens Leadership and Board of Directors
New CEO and board appointees from Labcorp, CVS Health and Northpond Ventures join to fuel company’s rapid growth and leadership position within the clinical trials market … Read More
